Shares of Elanco Animal Health (NYSE: ELAN) tumbled 21.1% last month, according to data from S&P Global Market Intelligence. The animal health giant reported second-quarter and first-half 2019 operating results that reflected the headwinds in global livestock markets, although operating margins improved thanks to lower cost of goods sold.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,